Scanfil Oyj · OMXHEX:SCANFL
Scanfil Oyj — Scanfil Oyj Ord — Q1 2025 Earnings Presentation
27 slides from Scanfil Oyj's earnings presentation, Apr 24, 2025
Slide 1: Quarter unfold as expected confirming positive view on the year
Quarter unfold as expected confirming positive view on the year CHRISTOPHE SUT, CEO KAI VALO, CFO 24 APRIL 2025 CONFIDENTIAL
Slide 2: Key events in Q1/2025
Key events in Q1/2025 Laerdal Medical Group structure Investment in Malaysia M&A • Production to start in Johor • New structure with four • Investment of EUR 4.3 million • We have built M&A and Bahru mid-2025 regions in Malaysian factory due to integration capabilities for the • Laerdal is a leader
Slide 3: Q1 2025 key financials
Q1 2025 key financials SCANFIL
Slide 4: Quarter unfold as expected confirming positive view on the year
Quarter unfold as expected confirming positive view on the year • Q1 impacted by new project ramp ups – business gaining Q1 2025 momentum towards the end of the quarter 192.6 M€ / -3.2% • New won deals continue at good level EUR 46.7 million Turnover / YoY, % • Energy & Cleantech stable and showing
Slide 5: Turnover and EBITA
Turnover and EBITA MEUR MEUR % 5
Slide 6: Americas
Americas Turnover EBITA Growth initiatives • Strong customer demand, • Several New Product • New PCBA line is in use and especially in electronics Introductions (NPIs) effected volume ramping up manufacturing profitability
Slide 7: APAC
APAC Turnover EBITA Growth initiatives • Good demand in China • Several New Product • Investment in a new PCBA line Introductions (NPIs) effected to modernize and increase • First new customer to profitability capacity of Malaysian Malaysia since the acquisition operations
Slide 8: Central Europe
Central Europe Turnover EBITA Growth initiatives • Project-based customer • Several New Product • Improvement of Sieradz demand and Energy & Introductions (NPIs) effected operations Cleantech had a negative profitability • High number of customer effect on turnover activities and visits
Slide 9: Northern Europe
Northern Europe Turnover EBITA Growth initiatives • Swedish operation affected • Volumes declined, but • Defense and Medtech & Life negatively by project-driven profitability held Science continue to drive demand sales
Slide 10: Customer group development
Customer group development 24-Apr-25 10
Slide 11: Industrial
Industrial Turnover Won deals Biggest won deals in Q1 2025 Y/Y: -3.2% 110 99,9 3.0 MEUR Engineering 100 94,2 90,4 91,1 90 3.0 MEUR Building & Construction 83,9 80 2.0 MEUR Mining 70 … … 60 15.4 MEUR In total 50 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25
Slide 12: Energy & Cleantech
Energy & Cleantech Turnover Won deals Biggest won deals in Q1 2025 Y/Y: -11.2% 80 70,4 72,4 67,5 13.1 MEUR Circular economy 70 62,5 60 55,6 4.9 MEUR General 50 1.5 MEUR Climate change adaption 40 … … 30 24.8 MEUR In total 20 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25
Slide 13: Medtech & Life Science
Medtech & Life Science Turnover Won deals Biggest won deals in Q1 2025 Y/Y: 13.3% 45 40 38,9 2.2 MEUR Environmental sensor 37,6 34,3 33,8 1.3 MEUR Analytical equipment 30 1.1 MEUR Laboratory analyzer … … 6.4 MEUR In total 15 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25
Slide 14: Financials
mlarclarersits CFO Kai Valo SCANFIL
Slide 15: EBITA waterfall January - March YTD
EBITA waterfall January - March YTD MEUR -3,2% • The turnover for the Q1 was EUR 192.6 million, EUR -6.3 or -3.2 % y/y. • Operational costs decreased by EUR -5.8 million or -3.1%, nearly compensating the lower turnover. • The EBITA-margin was at 6.5 % (6.6%). -3,1% 6,6% 6,4% 6,5% 6,2% 6,1% • 6,5% fo
Slide 16: Strong financial position
Strong financial position EUR 561.9 million • Inventories 169.7 (198.7) • Cash and cash equivalents totaled EUR 58.5 (22.3) million • Fixed Assets 96.1 (85.9) • Interest-bearing debt totaled EUR 74.4 (69.5) million • Equity per share was EUR 4.62 (4.21) 24-Apr-25 16
Slide 17: Strong cash generation
Strong cash generation • Net cash flow from operating activities was MEUR MEUR 79,5 MEUR 93.4 11.0 (9.7) and free cash flow after investments was EUR 9.3 (5.0) million • TTM Net cash flow from operating activities was EUR 93.4 (79.5) million, which is supported by EUR 29.0 million inventory reductio
Slide 18: Significant decline in net debt
Significant decline in net debt MEUR • Net debt was EUR 15.9 (47.2) million • Cash and cash equivalents totaled EUR 58.5 (22.3) million • Interest-bearing liabilities were EUR 74.4 (69.5) million • Total liquidity EUR 203.0 (110.9) million • EUR 144.5 (88.6) million in unused credit facilities • Cas
Slide 19: Key figures
Key figures Equity Ratio, % ROE, % • Equity ratio 54.9% (55.5%) 56 55,5 16 14,5 54,9 14 • Equity increased by EUR 26.8 million 55 12 11,2 • Balance sheet was up by EUR 43.9 54 million 10 53 8 6 52 • Net gearing 5.3% (17.1%) 4 51 2 • Net debt was EUR 15.9 million and decreased by EUR 31.3 million 50
Slide 20: Dividend has grown since 2012
Dividend has grown since 2012 • The Board proposes to pay 41% of the EPS i.e. EUR 0.24 per share CAGR 16.1% 40% 36% 33% 53% n/a 28% 29% 34% 30% 41% 39% 31% 41% 20
Slide 21: Outlook
Outlook
Slide 22: Outlook and focus in 2025
Outlook and focus in 2025 We expect our turnover to be EUR 780–920 million and comparable EBITA of EUR 55–68 million. The first quarter was a ramp-up quarter for the projects won in 2024. Momentum builds-up and turnover and EBITA is expected to be increase. Focus areas: • Build up sales pipeline wit
Slide 23: Q&A
SCANFIL Q&A
Slide 24: Key takeaways
Key takeaways • Q1/2025 • Regional segment reporting started • EBITA replaced Operating Profit (EBIT) in the guidance • Transition quarter with significant number of project ramp-ups and NPIs • Comparable EBITA margin remained stable at 6.5% (6.6%) • Gearing for growth • Investment in a new SMT line
Slide 25: Contact information and analysts
Carnegie AB, Stockholm Jakob Söderblom +46 734 178 643 jakob.soderblom@carnegie.se Contact information Inderes Oyj and analysts Antti Viljakainen +358 44 591 2216 antti.viljakainen(at)inderes.fi Nordea Oyj Pasi Väisänen CHRISTOPHE SUT, CEO +358 9 5300 5192 +358 407 318 411 pasi.vaisanen(at)nordea.co
Slide 26: Disclaimer
Disclaimer Not to be published or distributed, directly or indirectly, in any country where its distribution or publication is unlawful. Forward looking statements: certain statements in this presentation may constitute "forward-looking" statements which involve known and unknown risks, uncertaintie
Slide 27: Global contract manufacturer and systems supplier
Global contract manufacturer and systems supplier